Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Gabelli Funds to Host 31st Annual Aerospace & Defense Symposium at The Harvard Club, New York City Thursday, September 4, 2025
-
STMicroelectronics Announces Status of Common Share Repurchase Program
-
JDE Peet’s share buyback periodic update August 4, 2025
-
Arbe to Participate in Upcoming Investor Conferences
-
Lead Real Estate Co., Ltd Announces Sale of Two Apartment Hotels and Signing of Sales Contracts for Two Condominiums with Samurai Capital Co., Ltd
-
Dimensional Fund Advisors Ltd. : Form 8.3 - PRIMARY HEALTH PROPERTIES - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - MITIE GROUP PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - GREENCORE GROUP PLC - Ordinary Shares
-
ParaZero Technologies Ltd. Announces $2.2 Million Registered Direct Offering
-
Dimensional Fund Advisors Ltd. : Form 8.3 - ASSURA PLC - Ordinary Shares
-
Glass House Brands Provides Updates to Recent Events
-
UPCX Limited-Time Staking Event: Share a $16,000 Prize Pool + Unlimited Airdrops
-
Transactions in connection with share buyback programme
-
Quantum BioPharma Files Reply and Provides Update on Court Case Seeking Damages Against CIBC, RBC and Others in Excess of $700,000,000 USD for Possible Stock Price Manipulation/Spoofing
-
Tyson Foods Reports Third Quarter 2025 Results
-
Artelo Biosciences Announces $9.475 Million At-the-Market Private Placement to Initiate Solana Treasury Strategy, Becoming First Publicly-Traded Pharmaceutical Company to Adopt SOL as a Core Reserve A
-
Cassava Sciences Reports Positive Preclinical Study Evaluating Simufilam for TSC-Related Epilepsy
-
Zevra Therapeutics Announces Details for Q2 2025 Financial Results Call
-
Dyne Therapeutics Announces FDA Breakthrough Therapy Designation for DYNE-251 in Duchenne Muscular Dystrophy (DMD)
-
XOMA Royalty Enters into Agreement to Acquire LAVA Therapeutics for Between $1.16 and $1.24 Per Share in Cash, Plus a Contingent Value Right
-
MediWound to Report Second Quarter 2025 Financial Results
-
Digi Power X Reports 122% Month-Over-Month Increase in Cash and Crypto Position with No Long-Term Debt and Reports July 2025 Production Results
-
Stardust Power Announces Second Quarter 2025 Earnings Release Date, Conference Call
-
Mobiquity Technologies Launches CMOne – A Fully Agentic AI Marketing Platform for Unified Brand Engagement
-
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Transactions in connection with share buy-back program
-
Victus Global Launches $10 Million Fund to Back Emerging Low-Cap Blockchain Projects
-
LYNO AI Launches Early Bird Presale with Real-Time Machine Learning-Powered Arbitrage Protocol
-
ParaZero Announces Preliminary Unaudited Results for the First Six Months of 2025
-
Little Tikes Unleashes Unlimited Imagination with the Dr. Seuss® Edition Story Dream Machine™
-
Qubit Launches Quantum-Secured Wallet App for Web3 Users Across iOS and Android
-
OraSure Appoints Anne Messing as Chief Commercial Officer
-
Kraig Biocraft Laboratories Sets New Production Record and Advances Spider Silk Reeling with Successful Implementation of Automated Reeling Equipment
-
Tower Semiconductor Reports 2025 Second Quarter Financial Results
-
Atavistik Bio Announces First Patient Dosed in Phase 1 Clinical Trial of ATV-1601 in Patients with AKT1 E17K-mutant Solid Tumors
-
TMC Releases Two Economic Studies with Combined NPV of $23.6B and Declares World-First Nodule Reserves
-
Brady Corporation Acquires Mecco
-
GXO Strengthens Aerospace Business with RTX’s Pratt & Whitney Contract Renewal in the U.S.
-
Krystal Biotech Announces Second Quarter 2025 Financial and Operating Results
-
DallasNews Corporation Files Preliminary Proxy Statement
-
BioCryst Reports Second Quarter 2025 Financial Results and Provides Business Update
-
Kaspi.kz 2Q & 1H 2025 Financial Results
-
SINTX Technologies Expands Silicon Nitride Platform into Hybrid CFR-PEKK Trauma Plates
-
Kymera Therapeutics to Report Second Quarter 2025 Financial Results on August 11, 2025
-
TG Therapeutics Reports Second Quarter 2025 Financial Results and Raises BRIUMVI Revenue Guidance
-
Axsome Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update
-
Nevada Gold Mines and Komatsu Launch First-of-Its-Kind Autonomous Haulage Partnership in the U.S.
-
Kaspi.kz 2Q & 1H 2025 Financial Results
-
DallasNews Corporation Files Preliminary Proxy Statement
-
HilleVax Enters into a Definitive Agreement to be Acquired by XOMA Royalty for $1.95 in Cash per Share Plus a Contingent Value Right
